Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications
Cancer immunotherapy has shown impressive anti-tumor activity in patients with advanced and early-stage malignant tumors, thus improving long-term survival. However, current cancer immunotherapy is limited by barriers such as low tumor specificity, poor response rate, and systemic toxicities, which...
Saved in:
Main Authors: | Peijie Wu (Author), Jun Han (Author), Yanju Gong (Author), Chao Liu (Author), Han Yu (Author), Na Xie (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in Polymeric Micelles: Responsive and Targeting Approaches for Cancer Immunotherapy in the Tumor Microenvironment
by: Lichun Cheng, et al.
Published: (2023) -
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
by: Xin Zhang, et al.
Published: (2023) -
Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment
by: Emily B. Harrison, et al.
Published: (2018) -
Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment
by: Yunlong Shan, et al.
Published: (2022) -
Targeting the Tumor Microenvironment for a More Effective and Efficient Cancer Immunotherapy
Published: (2020)